CURE - Oncology & Cancer News for Patients & Caregivers
CURE - Oncology & Cancer News for Patients & Caregivers
Spotlight
BlogsClinical Trial CornerCURE's 20th Anniversary CelebrationPodcastsPublicationsRecipesVideos
Cancer Type
View MoreBladderBreastCLLKidneyLungMCLOvarianProstateSkin
About CURE
Press ReleasesShare Your StoryWrite for CURE
News
Cancer Horizons
All News
Blogs
Caregiving
Diet and Exercise
Financial
Psychosocial
Recipes
Sexual Health
Side Effect
Sponsored
Survivorship
Videos
All Videos
CURE Connections
CURE Expert Connections
CURE Speaking Out
CURE TV
On Demand: Award Programs
On Demand: Patient Summits
On Demand: Webinars
Conferences
Conference Coverage
Conference Listing
Events
CURE Adventures
Award Programs
Educated Patient Summits
Educated Patient Webinars
Resources
Advocacy Groups
Art Gallery
Clinical Trial Corner
CURE Ambassador Program
Educated Patient Research Updates
Interactive Tools
Journey
Partners
Podcasts
Publications
Share Your Story
Subscribe
CURE Magazine
HEAL Magazine
Sign Up for eNews
  • About
  • Advertise / Support
  • Contact
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information

© 2022 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.

Select a Cancer Type:

Leukemia

Bladder

Breast

Gastrointestinal

Gynecologic

Head & Neck

Kidney

Leukemia

Liver

Lung

Lymphoma

MPNs

Myeloma

Ovarian

Prostate

Skin/Melanoma

Overview

Types of Disease

Diagnosis

Treatment

Living with Cancer

Leukemia

RELATED ARTICLES

FDA OKs Continued Enrollment in Ongoing Blood Cancer Clinical Trials After Gilead Addresses Safety Concerns
April 15th, 2022
Earlier in the year, clinical trials assessing magrolimab for myelodysplastic syndrome and acute myeloid leukemia were put on a partial clinical hold, but now the FDA said that they can start enrolling patients again.
New Treatments Lend a Positive Outlook to Patients With GVHD
February 28th, 2022
There are now more drugs than ever to treat and prevent graft-versus-host disease in patients with blood cancer who receive a stem cell transplant.
Trial Initiated to Study Protein-Inhibiting Treatment Option for Patients With Acute Leukemia
February 17th, 2022
A trial to examine BMF-219 in patients with relapsed or refractory acute leukemias has begun recruiting patients across multiple U.S. states.
Leukemia Risk Factors
October 11th, 2018
Is there anything that we can do to lessen our child’s risk of developing this terrible disease? Let’s talk today about leukemia risk factors and its effect on kids